Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Josep Maria Jansat
Observed names:
Josep Jansat,
Josep M Jansat,
Josep M. Jansat
Institution:
Almirall (Spain)
Observed institution:
Almirall (Spain)
OpenAlex ID:
A5108371006
Incurred Sample Reproducibility: Views and Recommendations by the European Bioanalysis Forum
2009
·
Philip Timmerman
, Silke Luedtke
, et al.
·
Bioanalysis
·
89
Effect of MAO‐A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans
2001
·
Joseph C. Fleishaker
, Kristi K. Ryan
, et al.
·
British Journal of Clinical Pharmacology
·
54
PDF
Identification of the Human Liver Enzymes Involved in the Metabolism of the Antimigraine Agent Almotriptan
2003
·
Miquel Salva
, Josep M. Jansat
, et al.
·
Drug Metabolism and Disposition
·
50
Safety and Pharmacokinetics of Multiple Doses of Aclidinium Bromide, a Novel Long‐Acting Muscarinic Antagonist for the Treatment of Chronic Obstructive Pulmonary Disease, in Healthy Participants
2009
·
Josep M. Jansat
, Rosa Lamarca
, et al.
·
The Journal of Clinical Pharmacology
·
43
Ion Mobility–Mass Spectrometry for Bioanalysis
2021
·
Xavier Garcia
, Maria Sabaté
, et al.
·
Separations
·
33
PDF
Pharmacokinetics and safety of aclidinium bromide, a muscarinic antagonist, in adults with normal or impaired renal function: A phase I, open-label, single-dose clinical trial
2010
·
Karin Schmid
, Silvia Pascual
, et al.
·
Clinical Therapeutics
·
29
Absolute Bioavailability, Pharmacokinetics, and Urinary Excretion of the Novel Antimigraine Agent Almotriptan in Healthy Male Volunteers
2002
·
Josep M. Jansat
, Joan Costa
, et al.
·
The Journal of Clinical Pharmacology
·
28
Almotriptan, a New Anti‐Migraine Agent: A Review
2002
·
Jordi Gras
, Jesús Llenas
, et al.
·
CNS Drug Reviews
·
26
PDF
Pharmacokinetics and safety of aclidinium bromide in younger and elderly patients with chronic obstructive pulmonary disease
2012
·
Stephan de la Motte
, Jutta Beier
, et al.
·
International Journal of Clinical Pharmacology and Therapeutics
·
24
Activity of aclidinium bromide, a new long‐acting muscarinic antagonist: a phase I study
2010
·
Vanessa J. Schelfhout
, Pau Ferrer
, et al.
·
British Journal of Clinical Pharmacology
·
16
PDF
Safety and Tolerability of Aclidinium Administered Intravenously and Absolute Bioavailability of Inhaled Aclidinium in Healthy Male Participants
2011
·
Stephan Ortiz
, Stephen Flach
, et al.
·
The Journal of Clinical Pharmacology
·
13
Mass balance and metabolism of aclidinium bromide following intravenous administration of [14C]‐aclidinium bromide in healthy subjects
2012
·
Stephan Ortiz
, Stephen Flach
, et al.
·
Biopharmaceutics & Drug Disposition
·
10
Pharmacokinetic and Pharmacodynamic Studies of the Histamine H1-Receptor Antagonist Ebastine in Dogs
1994
·
Anna Puigdemont
, Mireia Queralt
, et al.
·
Journal of Pharmacy and Pharmacology
·
8
Safety And Pharmacokinetics Of Multiple Doses Of Aclidinium Bromide Administered Twice Daily In Healthy Volunteers
2011
·
Kenneth Lasseter
, Stacy Dilzer
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
3
Sensitive UHPLC–MS/MS Method for the Determination of Tacrolimus in Minipig Whole Blood
2020
·
Manuel Álvarez
, María Clotilde Hernández
, et al.
·
Bioanalysis
·
2
Show more works
View as search
Works count:
15
Citation count:
428
H-index:
11
I10-index:
12
Year
Topic
Type
